Thomson Medical Group (FRA:3H5) Accounts Payable: €53.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Thomson Medical Group Accounts Payable?

Thomson Medical Group FRA:3H5 +2.86% Accounts Payable is €53.2 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Thomson Medical Group's Accounts Payable for the quarter that ended in Dec. 2025 was €53.2 Mil.

Thomson Medical Group's quarterly Accounts Payable declined from Dec. 2024 (€61.5 Mil) to Jun. 2025 (€11.9 Mil) but then increased from Jun. 2025 (€11.9 Mil) to Dec. 2025 (€53.2 Mil).

Thomson Medical Group's annual Accounts Payable increased from Jun. 2023 (€8.7 Mil) to Jun. 2024 (€10.3 Mil) and increased from Jun. 2024 (€10.3 Mil) to Jun. 2025 (€11.9 Mil).

Thomson Medical Group Accounts Payable Related Terms

Thomson Medical Group Accounts Payable Historical Data

* Premium members only.

The historical data trend for Thomson Medical Group's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thomson Medical Group Accounts Payable Chart

Thomson Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.95 9.11 8.72 10.26 11.91

Thomson Medical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.82 10.26 61.48 11.91 53.24

Thomson Medical Group Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €53.2 Mil mean?
Thomson Medical Group (FRA:3H5) has a Accounts Payable of €53.2 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thomson Medical Group and its competitors.
Is Thomson Medical Group's Accounts Payable too high?
Thomson Medical Group's current Accounts Payable is €53.2 Mil.
How does Thomson Medical Group's Accounts Payable compare to HCA and THC?
Thomson Medical Group's Accounts Payable of €53.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thomson Medical Group and its competitors. Thomson Medical Group's current Accounts Payable is €53.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 28% below its estimated fair value. The current Accounts Payable is €53.2 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current Accounts Payable is €53.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thomson Medical Group Business Description

Other Exchanges A50:Singapore
Address 101 Thomson Road, No. 20-04/05, United Square, Singapore, SGP, 307591
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.